DAFTAR PUSTAKA

1. Djuanda A. Dermatosis Eritroskuamosa . Dalam : Djuanda A, Hamzah M,

Aisah S, ed. Ilmu Penyakit Kulit Dan Kelamin. Edisi ke-5. Jakarta : FK-UI.
2007. Hal. 189-196.
2. Gudjonsson JE, Elder JT. Psoriasis. In : Feedberg IM et al, Editors.
Fitzpatricks Dermatology In General Medicine. 5th Edition. Volume 1. New
York : The McGraw-Hill Companies; 2008. p. 163-193.
3. Griffiths C Camp R, Barker J. Psoriasis. In: Burns T, Breathnach S, Cox N,
Editors. Rooks Textbook Of Dermatology. 7th Edition. Volume 1-4. USA:
Blackwell Publishing. Massachusetts; 2004. p. 351-43.
4. Nestle FO, Kaplan DH, Barker J. Mechanism of Disease Psoriasis. New
England Jurnal of Medicine. Inggris: Massachusetts medical society. 2009;
361. 496-509.
5. Krueger JG, Bowcock A. Psoriasis Pathophysiologi : Current concept of
pathogenesis. Ann Rheum Dis 2005; 64: ii30-ii36.
6. Kerkhof P, Schalkwijk J. Psoriasis. In : Bolognia JL, Rapini RP, eds.
Dermatology. 2ndEdition. Vol. 1. Phiadelphia : Mosby; 2003. p. 125-40.
159-158
7. James WD, Berger TG, Elder JT. Psoriasis. Andrews Desease of The skin,
Clinical Dermatology. 10 ed. New York: Sauders Elsevier; 2006. p.193-201.
8. Jariwala SP. The Role of Dendritic Cells In the Imunopathogenesis
Psoriasis. Arch Dermatol Res 2007; 229 : 359-336.
9. Luba KM, Stulberg DL. Chronic Plaque Psoriasis. American Family
Physician. 2006; 73:637-44.
10. Habif TP. Psoriasis and other Papullosquamous Diseases. In: Hodgson S,
Cook L, Editors. Clinical Dermatology: A Colour Guide to Diagnosis and
Therapy. 4ed. London: Mosby Elsevier; 2004. p. 209-25
11. Suyono Y, Pohan SS, Joewarini E. Pemeriksaan Histopatologi Dalam
Menunjang Diagnosis Psoriasis. Berkala Ilmu Penyakit Kulit Dan Kelamin.
Surabaya. 2005. Hal.94.
12. Mobini N, Thoussaint S, Kamino H. Noinfectious erythematous, popular,
and squamous diseases. In: Elder DE, Elenitsas R, Johnson BL, Murphy GF,
editors. Levers Histopathology of the skin. 9 ed. Newyork: Lippincott
Wiliams & Wilkin; 2005. p. 184-92.
13. Stevenson O, Zaki I. Introduction to Psoriasis. Hospital Pharmacist.
2002;9:187-90.
14. Shaw JC. Psoriasis. In: Frankel DH, Editor. Field Guide to Clinical
Dermatology. 2ed. New York: Lippincott Williams & Wilkins; 2006. p.54-
6.
15. Wyatt EL, Sutter SH, Drake LA. Dermatological Pharmacology. In :
Hardman JG, Limbird LE, Eds. The Pharmacological Basis of Therapeutics.
10thEdition. New York : The McGraw-Hill Companies. 2006. p. 1804-9.
16. Vakirlis E, Kantanis A, Ioannides D. Calcipotriol/bethamethason
Dipropionate in the Treatment of Psoriasis Vulgaris. The Clin Risk Manag
2008 ; 4: 141-148
17. Marison LW. Drug Therapy in Dermatology. In : Milikan EL, editor.
Maryland : Johns Hopkins University; 2007. P. 253-264.
18. Jacobson CC, Kimball AB. Epidemiology Psoriasis. In: Gordon KB,
Ruderman EM, editors. Psoriasis and Psoriatic Arthritis. New York:
Spinger; 2005. p. 47-57
19. Wiryadi BE. Psoriasis penatalaksanaan. In : Tjarta A, Sularsito SA, Kurniati
DD, Rihatmaja R, editors. Metode Diagnostik dan Penatalaksanaan Psoriasis
dan Dermatitis Seboroik.
20. Toole JWP. Calcipotriol and Betamethasone Dipropionate for the Treatment
of Psoriasis: a 52-week study. Skin Therapy Letter. 2007;12:1-3